Clinical Trials Insurance

What We Offer

  • Annually renewable or full duration contracts
  • Off-the-shelf or bespoke insurance policies
  • Access to licensed paper in over 100 countries
  • Multi-territory programmes
  • Master policy contracts including Difference in Conditions / Difference in Limits provisions
  • Run-off cover extensions possible
  • Packages with other classes such as General Liability and Medical Malpractice

What We Target

  • Phase I, II, III and IV trials
  • Bio-equivalence and investigator-led studies
  • Sponsored trials of drug, medical device, nutraceutical and biotechnology companies
  • Contingent exposures of hospitals, charities and educational establishments
  • Biotechnology associations

Why We're Different

  • The best service, made possible by:
    • Lloyd’s license allowing extensive centralised policy issuance
    • In-house expertise allowing rapid quotation turnaround times
    • Partnership with the leading operators in this class
  • Trials of up to 10 years in study duration covered (with discovery / sunset periods in addition)
  • Fully compliant policies in native languages where applicable
  • Global knowledge of trials – we keep up to date with the frequent changes to regulatory and ethics committee policy requirements and listen to their feedback
  • Wide US appetite with ability to consider US trials by US parented companies
  • Competitive pricing that is sustainable and recognises the breadth of risk in this class

The Team

Daniel Starmer
  • Director of Life Science Liability
  • Mobile +44 (0) 77 1856 3782
Anthony Wright
  • International General Liability Principal Underwriter
  • Mobile +44 (0) 78 8546 3107
James Banks
  • Director of Healthcare
  • Mobile + 44 (0) 78 6167 9751